02 September 2022

Safety Alert for medical Recall for Pharmaceutical Product

Reference: CIR-2022-00000185

To all Health, facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated


Medical Product, Medical Product Recall, Antrolin Cream


Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector


Supporting Documents:

سحب المستحضر الطبي ِAntrolin Cream.pdf:

View Document